English  |  正體中文  |  简体中文  |  總筆數 :2856704  
造訪人次 :  53692354    線上人數 :  2221
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hsieh hp"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 231-255 / 265 (共11頁)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
國家衛生研究院 2006-07 Antiviral drug discovery against SARS-CoV Wu, YS;Lin, WH;Hsu, JTA;Hsieh, HP
國家衛生研究院 2006-06-15 Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies Tsai, KC; Chen, SY; Liang, PH; Lu, IL; Mahindroo, N; Hsieh, HP; Chao, YS; Liu, L; Liu, D; Lien, W; Lin, TH; Wu, SY
國家衛生研究院 2006-06-15 Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors Tsai, TY; Coumar, MS; Hsu, T; Hsieh, HP; Chien, CH; Chen, CT; Chang, CN; Lo, YK; Wu, SH; Huang, CY; Huang, YW; Wang, MH; Wu, HY; Lee, HJ; Chen, X; Chao, YS; Jiaang, WT
國家衛生研究院 2006-05-04 Structure-based drug design of a novel family of PPAR gamma partial agonists: Virtual screening, X-ray crystallography, and in vitro/in vivo biological activities Lu, IL; Huang, CF; Peng, YH; Lin, YT; Hsieh, HP; Chen, CT; Lien, TW; Lee, HJ; Mahindroo, N; Prakash, E; Yueh, A; Chen, HY; Goparaju, CMV; Chen, X; Liao, CC; Chao, YS; Hsu, JTA; Wu, SY
國家衛生研究院 2006-05 Antitubulin agents for the treatment of cancer - a medicinal chemistry update Mahindroo, N; Liou, JP; Chang, JY; Hsieh, HP
國家衛生研究院 2006-02-09 Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: Design, synthesis, structural biology, and molecular docking studies Mahindroo, N; Wang, CC; Liao, CC; Huang, CF; Lu, IL; Lien, TW; Peng, YH; Huang, WJ; Lin, YT; Hsu, MC; Lin, CH; Tsai, CH; Hsu, JTA; Chen, X; Lyu, PC; Chao, YS; Wu, SY; Hsieh, HP
國家衛生研究院 2006-01-12 2-[3-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-1,2,3,4-tetrahydroisoquinoline: A potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV Tsu, H; Chen, X; Chen, CT; Lee, SJ; Chang, CN; Kao, KH; Coumar, MS; Yeh, YT; Chien, CH; Wang, HS; Lin, KT; Chang, YY; Wu, SH; Chen, YS; Lu, IL; Wu, SY; Tsai, TY; Chen, WC; Hsieh, HP; Chao, YS; Jiaang, WT
國家衛生研究院 2006-01-01 Synthesis and anti-viral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon system Hwang, DR;Wu, YS;Chang, CW;Lien, TW;Chen, WC;Tan, UK;Hsu, JTA;Hsieh, HP
臺北醫學大學 2006 7-Aroyl-aminoindoline-1-sulfonamides as a Novel Class of Potent Antitubulin Agents 劉景平; 陳繼明; Chang JY; Hsieh HP; Chang CY; Hsu KS; Chiang YF; Chen CM; Kuo CC; Liou JP*
臺北醫學大學 2006 Antitubulin agents for the treatment of cancer-a medicinal chemistry update 劉景平; Mahindroo N; Liou JP; Chang JY; Hsieh HP
國家衛生研究院 2005-12-29 Novel indole-based peroxisome proliferator-activated receptor agonists: Design, SAR, structural biology, and biological activities Mahindroo, N; Huang, CF; Peng, YH; Wang, CC; Liao, CC; Lien, TW; Chittimalla, SK; Huang, WJ; Chai, CH; Prakash, E; Chen, CP; Hsu, TA; Peng, CH; Lu, IL; Lee, LH; Chang, YW; Chen, WC; Chou, YC; Chen, CT; Goparaju, CMV; Chen, YS; Lan, SJ; Yu, MC; Chen, X; Chao, YS; Wu, SY; Hsieh, HP
國家衛生研究院 2005-08-23 Indole compounds Hsieh, HP;Liou, JP;Chang, JY;Chang, CW
國家衛生研究院 2005-05 Shear stress inhibits smooth muscle cell-induced inflammatory gene expression in endothelial cells - Role of NF-kappa B Chiu, JJ; Chang, SF; Lee, PL; Lee, CI; Tsai, MC; Lee, DY; Hsieh, HP; Usami, S; Chien, S
國家衛生研究院 2005-05 Pharmaceutical design of antimitotic agents based on combretastatins Hsieh, HP;Liou, JP;Mahindroo, N
國家衛生研究院 2005-03 Promazine analogues as potential anti SARS-CoV drugs Hsieh, HP;Wu, YS;Lu, PH;Chen, CM;Chao, YC;Jan, JT;Huei-Ru, L;Ma, SH;Chao, YS;Hsu, TA
國家衛生研究院 2005-03 Design, synthesis and sar of indole-based PPAR agonists Hsieh, HP;Mahindroo, N;Coumar, MS;Wang, CC;Huang, CF;Lien, TW;Tsai, CH;Lin, YT;Lee, LH;Prakash, E;Hsu, TA;Chen, X;Wu, SY;Chen, CT;Chao, YS
國家衛生研究院 2005-03 Design and structure-activity relationships of novel indole-based PPAR agonists as antidiabetic agents Hsieh, HP;Mahindroo, N;Wang, CC;Huang, CF;Lien, TW;Tsai, CH;Peng, YH;Lee, LH;Prakash, E;Chen, WC;Chang, YW;Hsu, TA;Chen, X;Wu, SY;Chen, CT;Lan, SJ;Chao, YS
國家衛生研究院 2005 Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3 '- digallate (TF3) Chen, CN; Lin, CPC; Huang, KK; Chen, WC; Hsieh, HP; Liang, PH; Hsu, JTA
國家衛生研究院 2004-09-10 Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV Hsu, JTA; Kuo, CJ; Hsieh, HP; Wang, YC; Huang, KK; Lin, CPC; Huang, PF; Chen, X; Liang, PH
國家衛生研究院 2004-09 Drug design of BPR0L075 as an anticancer agent Hsieh, HP;Liou, JP;Chang, CW;Kuo, CC;Chang, YL;Kuo, FM;Tseng, HY;Pan, WY;Chen, CP;Yang, YN;Chen, CT;Lee, SJ;Chang, JY
國家衛生研究院 2004-08-22 Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents Hsieh, HP;Liou, JP;Chang, YL;Lee, SJ
國家衛生研究院 2004-08-12 Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents Liou, JP; Chang, YL; Kuo, FM; Chang, CW; Tseng, HY; Wang, CC; Yang, YN; Chang, JY; Lee, SJ; Hsieh, HP
國家衛生研究院 2004-07-15 A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells Juang, SH; Pan, WY; Kuo, CC; Liou, JP; Hung, YM; Chen, LT; Hsieh, HP; Chang, JY
國家衛生研究院 2004-07-01 BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo Kuo, CC; Hsieh, HP; Pan, WY; Chen, CP; Lion, JP; Lee, SJ; Chang, YL; Chen, LT; Chen, CT; Chang, JY
國家衛生研究院 2004-07 Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide Wu, CJ; Jan, JT; Chen, CM; Hsieh, HP; Hwang, DR; Liu, HW; Liu, CY; Huang, HW; Chen, SC; Hong, CF; Lin, RK; Chao, YS; Hsu, JTA

顯示項目 231-255 / 265 (共11頁)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每頁顯示[10|25|50]項目